Endra Life Sciences Inc (NDRA) Stock Price, Quote & News

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 734 335 0468

Website: endrainc.com

Address:

3600 Green Court, Suite 350, Ann Arbor, United States

JohnGadwin May. 13 at 8:08 AM

$FCHL next one is $NDRA Low floaters on fire

0 · Reply

topstockalerts May. 13 at 1:10 AM

$NDRA there’s a certain stubbornness to this strength.

0 · Reply

ProWinners May. 8 at 6:10 PM

$NDRA Thin one

0 · Reply

SuperGreenToday May. 7 at 11:46 AM

$NDRA

0 · Reply

NewsAndFilings May. 4 at 7:26 PM

SmallCaps in Focus: $CNSP, $PN, $GBTG, $NDRA — Key Catalysts, Emerging Market Trends https://thestreetreports.com/smallcaps-in-focus-cnsp-pn-gbtg-ndra-key-catalysts-emerging-market-trends/

1 · Reply

NewsAndFilings May. 1 at 3:49 PM

ENDRA Life Sciences (NASDAQ: $NDRA) Emerging Diagnostic Infrastructure Catalyst in MASLD as GLP-1 Boom Accelerates — See Other Active Stocks https://thestreetreports.com/endra-life-sciences-nasdaq-ndra-emerging-diagnostic-infrastructure-catalyst-in-masld-as-glp-1-boom-accelerates-see-other-active-stocks/

0 · Reply

OfficialStocktwitsUser Apr. 28 at 7:52 PM

$NDRA RSI: 44.02, MACD: 0.2108 Vol: 0.45, MA20: 5.12, MA50: 4.26 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

NewsAndFilings Apr. 28 at 6:11 PM

ENDRA Life Sciences (NASDAQ: $NDRA) Heats Up as Diagnostic Play Targeting GLP-1 Bottleneck – See Comparison Stocks Inside https://thestreetreports.com/endra-life-sciences-nasdaq-ndra-heats-up-as-diagnostic-play-targeting-glp-1-bottleneck-see-comparison-stocks-inside/

0 · Reply

topstockalerts Apr. 28 at 12:15 PM

Pre Market Top Gainers PT2 $NEXR $NDRA $IDXX $DDI $LGIH

0 · Reply

NewsAndFilings Apr. 27 at 6:56 PM

Small Cap The Street Reports Focus: $RDZN $TOON $ANY.X $NDRA $PRSO https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177543520

0 · Reply

Endra Life Sciences reports Q4 EPS ($8.93) vs ($56.94) last year

Mar 31, 2026, 4:05 PM EDT - 6 weeks ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

2026-03-25T12:06:25.000Z - 6 weeks ago

Endra Life Sciences initiates review of strategic alternatives

Mar 25, 2026, 8:00 AM EDT - 6 weeks ago

ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

2026-02-26T14:33:33.000Z - 2 months ago

Endra Life Sciences announces favorable TAEUS liver device study results

Feb 26, 2026, 8:00 AM EST - 2 months ago

ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

2025-12-04T13:20:28.000Z - 5 months ago

Endra Life Sciences announces results from Taeus Liver device feasibility study

Dec 4, 2025, 8:00 AM EST - 5 months ago

ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Nov 20, 2025, 8:00 AM EST - 6 months ago

ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

Nov 17, 2025, 8:00 AM EST - 6 months ago

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

2025-11-13T14:25:52.000Z - 6 months ago

Endra Life Sciences commences staking of HYPE digital asset holdings

Nov 13, 2025, 8:00 AM EST - 6 months ago

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

2025-11-06T22:05:26.000Z - 6 months ago

Endra Life Sciences files to sell 2.68M shares of common stock for holders

Oct 23, 2025, 8:00 AM EDT - 7 months ago

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Oct 13, 2025, 8:00 AM EDT - 7 months ago

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

2025-08-14T20:15:23.000Z - 9 months ago

Endra Life Sciences reports Q2 EPS ($1.71) vs. (8c) last year

Aug 14, 2025, 4:05 PM EDT - 9 months ago

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

2025-07-09T13:15:12.000Z - 10 months ago

Endra Life Sciences files to sell 15.7M shares of common stock

Jun 16, 2025, 8:00 AM EDT - 11 months ago

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

2025-05-15T20:15:45.000Z - 1 year ago

Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year

May 15, 2025, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

2025-05-09T14:02:48.000Z - 1 year ago

ENDRA Life Sciences Inc trading resumes

2025-05-09T13:58:10.000Z - 1 year ago

ENDRA Life Sciences Inc trading halted, volatility trading pause

Mar 31, 2025, 8:05 AM EDT - 1 year ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Mar 31, 2025, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

2024-11-29T16:15:26.000Z - 1 year ago

ENDRA Life Sciences Inc trading resumes

2024-11-29T16:10:16.000Z - 1 year ago

ENDRA Life Sciences Inc trading halted, volatility trading pause

2024-11-22T13:11:13.000Z - 1 year ago

Endra Life Sciences regains compliance with Nasdaq

Nov 22, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 15, 2024, 9:24 AM EST - 1 year ago

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

2024-11-07T14:40:28.000Z - 1 year ago

ENDRA Life Sciences Inc trading resumes

2024-11-07T14:35:28.000Z - 1 year ago

ENDRA Life Sciences Inc trading halted, volatility trading pause

2024-11-07T00:51:43.000Z - 1 year ago

ENDRA Life Sciences Inc trading halted, news pending

2024-11-06T13:11:21.000Z - 1 year ago

Endra Life Sciences issued new European patent

Nov 6, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

2024-10-22T12:21:36.000Z - 1 year ago

Endra activates TAEUS system to initiate clinical study at LMU in Germany

Oct 22, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Aug 28, 2024, 4:17 PM EDT - 1 year ago

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Aug 22, 2024, 4:30 PM EDT - 1 year ago

ENDRA Life Sciences Earnings Call Transcript: Q2 2024

Aug 22, 2024, 4:14 PM EDT - 1 year ago

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 16, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Reverse Stock Split

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Aug 13, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Leadership Changes

Aug 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Jun 4, 2024, 9:21 AM EDT - 2 years ago

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Jun 4, 2024, 9:06 AM EDT - 2 years ago

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

May 20, 2024, 8:00 AM EDT - 2 years ago

ENDRA Provides Update Following In-person Meeting with FDA

May 14, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 7, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

Mar 28, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 21, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Feb 27, 2024, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 21, 2024, 8:00 AM EST - 2 years ago

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Feb 14, 2024, 8:30 AM EST - 2 years ago

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Nov 29, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Nov 27, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

Nov 14, 2023, 4:30 PM EST - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

Nov 7, 2023, 4:05 PM EST - 2 years ago

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 6, 2023, 8:00 AM EST - 2 years ago

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Sep 7, 2023, 8:00 AM EDT - 2 years ago

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

Aug 30, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

Aug 23, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

Aug 14, 2023, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

Aug 14, 2023, 1:30 PM EDT - 2 years ago

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

Aug 1, 2023, 8:00 AM EDT - 3 years ago

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

Jul 6, 2023, 4:45 PM EDT - 3 years ago

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Jun 7, 2023, 8:00 AM EDT - 3 years ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

JohnGadwin May. 13 at 8:08 AM

$FCHL next one is $NDRA Low floaters on fire

0 · Reply

topstockalerts May. 13 at 1:10 AM

$NDRA there’s a certain stubbornness to this strength.

0 · Reply

ProWinners May. 8 at 6:10 PM

$NDRA Thin one

0 · Reply

SuperGreenToday May. 7 at 11:46 AM

$NDRA

0 · Reply

NewsAndFilings May. 4 at 7:26 PM

SmallCaps in Focus: $CNSP, $PN, $GBTG, $NDRA — Key Catalysts, Emerging Market Trends https://thestreetreports.com/smallcaps-in-focus-cnsp-pn-gbtg-ndra-key-catalysts-emerging-market-trends/

1 · Reply

NewsAndFilings May. 1 at 3:49 PM

0 · Reply

OfficialStocktwitsUser Apr. 28 at 7:52 PM

0 · Reply

NewsAndFilings Apr. 28 at 6:11 PM

0 · Reply

topstockalerts Apr. 28 at 12:15 PM

Pre Market Top Gainers PT2 $NEXR $NDRA $IDXX $DDI $LGIH

0 · Reply

NewsAndFilings Apr. 27 at 6:56 PM

Small Cap The Street Reports Focus: $RDZN $TOON $ANY.X $NDRA $PRSO https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177543520

0 · Reply

Moondusterke Apr. 22 at 4:23 AM

$NDRA can we see a 3 to 5% rebounce or will it go down to 4,60$ - 4,70$ zone? We will notice it verry soon.

0 · Reply

Rasto2020 Apr. 21 at 12:17 AM

$NDRA creeping up on now volume, hm

0 · Reply

MikeTechnician Apr. 20 at 7:52 PM

$NDRA basketball court historical awaits.

0 · Reply

MikeTechnician Apr. 20 at 7:17 PM

$NDRA ?

0 · Reply

NewsAndFilings Apr. 13 at 6:19 PM

ENDRA Life Sciences (NASDAQ: $NDRA) Targets Billions With TAEUS® Liver Imaging Technology https://thestreetreports.com/endra-life-sciences-nasdaq-ndra-targets-billions-with-taeus-liver-imaging-technology/

0 · Reply

NewsAndFilings Apr. 7 at 5:26 PM

ENDRA Life Sciences (NASDAQ: $NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside https://thestreetreports.com/endra-life-sciences-nasdaq-ndra-targets-masld-and-glp-1-imaging-bottleneck-with-taeus-as-stocks-under-5-gain-attention-inside/

0 · Reply

Buylocal Apr. 6 at 12:59 PM

$NDRA the pump before the massive stock sale. Need cash. Restating the same story for the twentieth time. Might as well throw your money on the lawn.

0 · Reply

NewsAndFilings Apr. 2 at 12:14 PM

Yesterday's Recap: $GOGR Aligns Commercialization Roadmap and Capital Strategy Following Strategic Board Session $ADMQ Reports $5.62M Revenue $SNYR Financial Results $NDRA Financial Results

0 · Reply

D3fiant Apr. 1 at 9:01 PM

$NDRA anyone know why WeDull restricted trading on this company. All you can do is close out positions now?

0 · Reply

MsGrumpy Apr. 1 at 3:05 PM

$NDRA ENDRA Life Sciences Inc. reported financial results for the quarter and year ended December 31, 2025 https://www.businesswire.com/news/home/20260331142790/en/ENDRA-Life-Sciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update john derienzo

0 · Reply

NewsAndFilings Apr. 1 at 12:30 PM

$NDRA ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update https://www.businesswire.com/news/home/20260331142790/en/ENDRA-Life-Sciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update

0 · Reply

Giants67 Apr. 1 at 12:06 PM

0 · Reply

Market Cap	6.27M
Revenue (ttm)	0.00
Net Income (ttm)	-7.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	23,800
Avg Vol	38,828
Day's Range	N/A - N/A
Shares Out	1.24M
Stochastic %K	100%
Beta	-0.11
Analysts	Sell
Price Target	$27.00